logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Illumina, Inc. completes acquisition of Fluent BioSciences to expand single-cell analysis capabilities

Jul 09, 2024•over 1 year ago

Acquiring Company

Illumina

Acquired Company

Fluent BioSciences

researchBiotechnology

Description

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, has acquired Fluent BioSciences, the developer of an emerging and highly differentiated single-cell technology. This acquisition will accelerate Illumina's capabilities in single-cell analysis and discovery, expanding its offerings to a broader customer base.

Company Information

Company

Illumina

Location

5200 Illumina Way

About

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube. Investors:Brian Blanchett858.291.6421 IR@illumina.com Media:Dr. Karen Birmingham646.355.2111 pr@illumina.com

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed